Wenjuan Jiang, Xinrong Yuan, Hong Zhu, Changsheng He, Caiqiong Ge, Qing Tang, Chuanting Xu, Bingfeng Hu, Cheng Huang, Taotao Ma
Frontiers in immunology 2020Nephrotoxicity is a major side effect of cisplatin (CP)- and platinum-related chemotherapy, and inflammation contributes to disease pathogenesis. Interleukin-9 (IL-9) is a pleiotropic cytokine associated with inflammation. Here, we investigated the key role of IL-9 as a regulator of protective mechanisms in CP-induced acute kidney injury (AKI). We observed that IL-9 was decreased not only in a CP-induced AKI mouse model but also in THP-1 and RAW264.7 cell lines. Seventy-two hours post-CP injection, renal dysfunction and tubule injury were significantly attenuated in IL-9 overexpression adeno-associated virus 9 (AAV9)-treated mice. The levels of serum urea, serum creatinine, kidney injury molecule-1 (KIM-1), and histological damage were partially diminished following treatment with IL-9. The renoprotective effects of IL-9 may be attributed to the regulation of cytokines, and we found that IL-9 acted on macrophages in a regulatory manner, promoting an anti-inflammatory phenotype. Furthermore, IL-9 enhanced the suppression of macrophage-driven renal inflammation. Inhibition of H3K27 acetylation orchestrated IL-9-mediated renoprotection in CP-induced AKI. Thus, our findings indicate novel and potent anti-inflammatory properties of IL-9 that confer preservation of kidney function and structure in CP-induced AKI, which may counteract kidney disease procession. Copyright © 2020 Jiang, Yuan, Zhu, He, Ge, Tang, Xu, Hu, Huang and Ma.
Wenjuan Jiang, Xinrong Yuan, Hong Zhu, Changsheng He, Caiqiong Ge, Qing Tang, Chuanting Xu, Bingfeng Hu, Cheng Huang, Taotao Ma. Inhibition of Histone H3K27 Acetylation Orchestrates Interleukin-9-Mediated and Plays an Anti-Inflammatory Role in Cisplatin-Induced Acute Kidney Injury. Frontiers in immunology. 2020;11:231
PMID: 32194547
View Full Text